Inter Pipeline Fd A (IPPLF) 26.1900 $IPPLF Inter

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Inter Pipeline Fd A (IPPLF) 26.1900 $IPPLF

Inter Pipeline Adopts Shareholder Protection Rights Plan
Marketwire - Mon Mar 24, 6:19PM CDT
Inter Pipeline Ltd. ("Inter Pipeline") (TSX: IPL) announced today that effective immediately its Board of Directors ("the Board") has adopted a Shareholder Protection Rights Plan ("Rights Plan"). The purpose of the Rights Plan is to grant shareholders and the Board adequate time to consider and evaluate any unsolicited takeover bid made for Inter Pipeline's common shares ("Shares"). The Rights Plan provides the Board with the flexibility to identify and negotiate value-enhancing alternatives, and encourage the fair treatment of shareholders in connection with any takeover bid. The Rights Plan is similar to existing shareholder rights plans adopted by other Canadian public companies, and has not been adopted in anticipation of any known take-over bid.

Inter Pipeline Announces March 2014 Cash Dividend
Marketwire - Thu Mar 06, 9:03AM CST
Inter Pipeline Ltd. ("Inter Pipeline") (TSX: IPL) announced today the declaration of a cash dividend of $0.1075 per share for March 2014. This dividend will be paid on or about April 15th, 2014 to shareholders of record on March 21st, 2014. This dividend is designated as an "eligible dividend" for Canadian tax purposes.

Inter Pipeline Announces Record 2013 Financial and Operating Results
Marketwire - Thu Feb 20, 10:17AM CST
Inter Pipeline Ltd. ("Inter Pipeline") (TSX: IPL) announced today record financial and operating results for the three and twelve month periods ended December 31, 2013.

Inter Pipeline Announces February 2014 Cash Dividend
Marketwire - Thu Feb 06, 9:41AM CST
Inter Pipeline Ltd. ("Inter Pipeline") (TSX: IPL) announced today the declaration of a cash dividend of $0.1075 per share for February 2014. This dividend will be paid on or about March 14th, 2014 to shareholders of record on February 24th, 2014. This dividend is designated as an "eligible dividend" for Canadian tax purposes.

Inter Pipeline Ltd. - Year End 2013 Conference Call and Webcast
Marketwire - Wed Feb 05, 9:18AM CST
Inter Pipeline Ltd. ("Inter Pipeline") (TSX: IPL) will announce its year end 2013 financial and operating results on February 20, 2014 and has scheduled a conference call and webcast to begin at 2:30 p.m. (Mountain Time) / 4:30 p.m. (Eastern Time) the same day for interested shareholders, analysts and media representatives.

Inter Pipeline Announces $1.3 Billion Capital Expenditure Program for 2014
Marketwire - Wed Jan 29, 8:21AM CST
Inter Pipeline Ltd. ("Inter Pipeline") (TSX: IPL) announced today a $1.3 billion capital expenditure program for 2014, primarily directed towards the expansion of its oil pipeline systems. Rising customer demand for transportation capacity in the oil producing regions serviced by Inter Pipeline has driven $3.4 billion in capital investment since 2012. Organic growth projects are expected to account for about 97 percent of 2014's total expenditures, with modest sustaining capital requirements accounting for the remainder.

Inter Pipeline Announces January 2014 Cash Dividend
Marketwire - Thu Jan 09, 8:36AM CST
Inter Pipeline Ltd. ("Inter Pipeline") (TSX: IPL) announced today the declaration of a cash dividend of $0.1075 per share for January 2014. This dividend will be paid on or about February 14th, 2014 to shareholders of record on January 22nd, 2014. This dividend is designated as an "eligible dividend" for Canadian tax purposes.

Inter Pipeline Announces Appointment of New Chief Financial Officer
Marketwire - Wed Jan 08, 9:30AM CST
Inter Pipeline Ltd. ("Inter Pipeline") (TSX: IPL) is pleased to announce that Brent Heagy has been appointed Chief Financial Officer effective March 1, 2014. Mr. Heagy will replace Bill van Yzerloo, whose planned retirement was disclosed earlier in 2013.

Athabasca Oil Corporation Announces Management Change
CNW Group - Wed Jan 08, 5:00AM CST
Athabasca Oil Corporation (TSX: ATH) ("Athabasca" or "the Company") announces that Kim Anderson has accepted an appointment to become the Company's Chief Financial Officer, replacing Brent Heagy who has chosen to leave the Company to pursue an opportunity as a CFO with Inter Pipeline Ltd. Mr. Heagy will be staying with the Company until mid-February in order to ensure a smooth transition of his responsibilities. Ms. Anderson and Mr. Heagy have previously worked together.

Inter Pipeline Announces December 2013 Cash Dividend
Marketwire - Thu Dec 05, 4:54PM CST
Inter Pipeline Ltd. ("Inter Pipeline") (TSX: IPL) announced today the declaration of a cash dividend of $0.1075 per share for December 2013. This dividend will be paid on or about January 15th, 2014 to shareholders of record on December 23rd, 2013. This dividend is designated as an "eligible dividend" for Canadian tax purposes.

Inter Pipeline Announces Board and Senior Management Changes
Marketwire - Thu Dec 05, 4:45PM CST
Inter Pipeline Ltd. ("Inter Pipeline") (TSX: IPL) today announced several changes regarding the composition of its board of directors and senior management team. These changes include the appointment of a new independent Chairman of the Board, the transition of Chief Executive Officer responsibilities and the appointment of a new Chair of the corporation's Governance Committee. The changes announced today are highly consistent with Inter Pipeline's previously announced intentions and internal succession plans.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 154

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 207

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 22

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 225

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 155

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 150

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 233

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
les" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles